MedTrace Logo

Permeability Map to Distinguish Progression From Pseudoprogression in High-Grade Glioma

NCT01499823 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2013-12-30

No results posted yet for this study

Summary

The aim of the present study is to assess whether a new method of quantifying therapy-associated hemodynamic alterations based on DCE MR imaging may help to distinguish pseudoprogression from true progression in patients with high grade glioma, who received CCRT.

Conditions

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • SeungHong Choi, MD, PhD · Seoul National University Hospital(Radiology)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2011-12-31
Completion
2013-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01499823 on ClinicalTrials.gov